相关实验视频

Updated: Jul 25, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

一种科尔奇辛毒性病例与优糖性糖尿病酸性脂肪酸症呈现

Sean D Delshad¹, Angela Kleiber¹

¹Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, USA.

|June 28, 2023

概括

科尔奇辛毒性虽然危险,但很少表现为euglycemic糖尿病酸性酸症 (DKA). 这一案例突出显示,在使用相互作用药物的患者中,DKA对胆固醇有毒性的罕见表现.

科学领域:

药理学药理学是指药理学的学科.
毒理学毒理学毒理学
内分泌学在内分泌学.

背景情况:

科尔奇辛是治疗某些炎症的有效药物,但其治疗窗口很窄.
胆固醇毒性可能导致严重的代谢障碍,多器官衰竭和死亡,特别是与CYP3A4和P-糖蛋白抑制剂结合使用时.
优糖性糖尿病酸性酸症 (DKA) 是某些药物的罕见但严重并发症.

研究的目的:

报告一种独特的科尔奇辛毒性病例,呈现为euglycemic糖尿病酸性酸症 (DKA).
强调药物毒性的罕见代谢表现的可能性.
为了突出与涉及科尔奇辛的药物相互作用相关的风险.

主要方法:

病例报告详细介绍了一名患者的病史,该患者有长期使用菌素的病史.
分析患者的病史,包括当前的药物 (克拉里思罗米,达帕格利弗洛辛) 和呈现症状.
文献综述记录的科尔奇辛毒性和euglycemic DKA的病例.

主要成果:

患者呈现出与素毒性和euglycemic DKA相一致的症状.
据我们所知,本次演示是首次记录的,最初表现为euglycemic DKA.卡尔奇辛毒性.
克拉里思罗米和达帕格利弗洛辛的同时使用可能导致了菌素毒性和DKA.

结论:

胆固醇毒性可能会出现罕见的代谢并发症,包括euglycemic DKA.
临床医生应考虑在患有DKA的患者中,特别是那些服用相互作用药物的患者中,对菌素的毒性.
意识到潜在的药物相互作用对于预防严重的菌素毒性至关重要.

关键词:

科尔奇辛中毒,可能是毒药.糖尿病酸性酸性糖尿病在正常的血糖水平下,dka.内部医学 (一般医学)导致euglycemic dka 的沉因素

更多相关视频

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

相关概念视频

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...